$3.55
0.123.50%
近くで: Feb 13, 4:00 PM EST
$3.60
0.174.96%
プレマーケット: 4:36 AM EST
Comments
Loading...
インサイダー取引活動
最新の Esperion Therapeutics インサイダー取引活動を追跡します。Esperion Therapeutics 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー活動とは何ですか?
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
Esperion Therapeutics Inc のインサイダーは何をしているのですか?
Esperion Therapeutics Incでは、最近の内部関係者の活動が注目を集めています。過去 30 日間で、内部関係者は合計 1.69K 株相当の $4.87K 株を売却したと報告しています。過去 30 日間に購入がなかったと報告します。
最近の注目すべきインサイダー売買
- 1 21, 2026、Benjamin Looker、会社の GENERAL COUNSEL sold 1.69K 株はそれぞれ 2.88 です。
- 12 18, 2025、Benjamin Looker、会社の GENERAL COUNSEL sold 6.52K 株はそれぞれ 3.67 です。
- 12 18, 2025、Benjamin Halladay、会社の CHIEF FINANCIAL OFFICER sold 7.34K 株はそれぞれ 3.67 です。
Esperion Therapeutics Inc の所有権統計
発行済み株式数
237.069M
浮動株
236186655.0%
インサイダー所有株式数
4.814M
インサイダー保有率
2.01%
機関投資家保有株式
72.590M
機関投資家保有比率
30.4%
| Jan 21, 2026 | Benjamin Looker | GENERAL COUNSEL | -1.69K | $2.88 | -$4.87K | SELL | -0.44% | 384.22K | Jan 20 | View |
| Dec 18, 2025 | Sheldon L Koenig | PRESIDENT AND CEO | -48.24K | $3.67 | -$177.20K | SELL | -3.18% | 1.47M | Dec 17 | View |
| Dec 18, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -7.34K | $3.67 | -$26.90K | SELL | -1.55% | 467.52K | Dec 17 | View |
| Dec 18, 2025 | Benjamin Looker | GENERAL COUNSEL | -6.52K | $3.67 | -$23.90K | SELL | -1.66% | 385.90K | Dec 17 | View |
| Oct 20, 2025 | Benjamin Looker | GENERAL COUNSEL | -1.25K | $2.62 | -$3.28K | SELL | -0.32% | 392.42K | Oct 17 | View |
| Sep 18, 2025 | Benjamin Looker | GENERAL COUNSEL | -6.27K | $2.80 | -$17.57K | SELL | -1.57% | 393.67K | Sep 17 | View |
| Sep 18, 2025 | Sheldon L Koenig | PRESIDENT AND CEO | -28.43K | $2.79 | -$79.25K | SELL | -1.84% | 1.52M | Sep 17 | View |
| Sep 18, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -7.05K | $2.81 | -$19.79K | SELL | -1.46% | 474.86K | Sep 17 | View |
| Jul 18, 2025 | Benjamin Looker | GENERAL COUNSEL | -1.30K | $1.13 | -$1.47K | SELL | -0.32% | 399.94K | Jul 17 | View |
| Jul 18, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -11.00 | $1.11 | -$12.27 | SELL | -0.00% | 474.46K | Jul 17 | View |
| Jun 18, 2025 | Benjamin Looker | GENERAL COUNSEL | -6.42K | $1.15 | -$7.40K | SELL | -1.58% | 401.24K | Jun 17 | View |
| Jun 18, 2025 | Sheldon L Koenig | PRESIDENT AND CEO | -30.47K | $1.11 | -$33.80K | SELL | -1.94% | 1.54M | Jun 17 | View |
| Jun 18, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -7.23K | $1.15 | -$8.33K | SELL | -1.50% | 474.47K | Jun 17 | View |
| Apr 21, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -108.00 | $0.98 | -$105.62 | SELL | -0.03% | 370.22K | Apr 17 | View |
| Apr 21, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -8.00 | $0.96 | -$7.71 | SELL | -0.00% | 481.70K | Apr 17 | View |
| Mar 19, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -3.54K | $1.48 | -$5.24K | SELL | -0.73% | 481.71K | Mar 18 | View |
| Mar 19, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.43K | $1.49 | -$3.62K | SELL | -0.65% | 370.33K | Mar 18 | View |
| Mar 19, 2025 | Sheldon L Koenig | PRESIDENT AND CEO | -13.05K | $1.50 | -$19.62K | SELL | -0.82% | 1.57M | Mar 18 | View |
| Feb 20, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -239.00 | $1.87 | -$446.45 | SELL | -0.15% | 159.76K | Feb 19 | View |
| Feb 20, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -11.00 | $1.86 | -$20.46 | SELL | -0.00% | 240.67K | Feb 19 | View |
| Jan 21, 2025 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -9.00 | $2.27 | -$20.39 | SELL | -0.00% | 240.68K | Jan 17 | View |
| Jan 21, 2025 | Eric Warren | CHIEF COMMERCIAL OFFICER | -123.00 | $2.26 | -$277.98 | SELL | -0.08% | 160.00K | Jan 17 | View |
| Dec 18, 2024 | Benjamin Halladay | CHIEF FINANCIAL OFFICER | -3.25K | $2.42 | -$7.87K | SELL | -1.33% | 240.69K | Dec 17 | View |
| Dec 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.23K | $2.43 | -$5.43K | SELL | -1.38% | 160.12K | Dec 17 | View |
| Dec 18, 2024 | Sheldon L Koenig | PRESIDENT AND CEO | -12.45K | $2.47 | -$30.69K | SELL | -1.65% | 739.82K | Dec 17 | View |
| Nov 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -197.00 | $2.17 | -$426.50 | SELL | -0.12% | 162.35K | Nov 19 | View |
| Oct 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -107.00 | $2.12 | -$226.73 | SELL | -0.07% | 162.55K | Oct 17 | View |
| Sep 18, 2024 | Sheldon L Koenig | PRESIDENT AND CEO | -14.55K | $1.80 | -$26.13K | SELL | -1.90% | 752.27K | Sep 17 | View |
| Sep 18, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.61K | $1.78 | -$4.65K | SELL | -1.58% | 162.66K | Sep 17 | View |
| Aug 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -211.00 | $1.95 | -$410.61 | SELL | -0.13% | 165.27K | Aug 19 | View |
| Jul 19, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -108.00 | $2.59 | -$279.40 | SELL | -0.07% | 165.48K | Jul 17 | View |
| Jul 19, 2024 | Joanne Foody | CHIEF MEDICAL OFFICER | -917.00 | $2.60 | -$2.38K | SELL | -0.33% | 272.86K | Jul 17 | View |
| Jun 20, 2024 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.29K | $2.87 | -$9.42K | SELL | -1.19% | 273.78K | Jun 18 | View |
| Jun 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -2.54K | $2.86 | -$7.25K | SELL | -1.51% | 165.59K | Jun 18 | View |
| May 20, 2024 | Eric Warren | CHIEF COMMERCIAL OFFICER | -192.00 | $2.48 | -$476.74 | SELL | -0.11% | 168.13K | May 17 | View |
| Sep 21, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -742.00 | $1.25 | -$923.79 | SELL | -1.07% | 68.32K | Sep 20 | View |
| Aug 21, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -243.00 | $1.41 | -$343.60 | SELL | -0.35% | 69.06K | Aug 18 | View |
| Jul 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -106.00 | $1.58 | -$168.01 | SELL | -0.15% | 69.30K | Jul 19 | View |
| Jun 22, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -603.00 | $1.48 | -$894.25 | SELL | -0.86% | 69.41K | Jun 21 | View |
| May 18, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -219.00 | $1.62 | -$355.66 | SELL | -0.31% | 70.01K | May 17 | View |
| May 11, 2023 | MARTIN CARROLL | DIRECTOR | 31.50K | $1.55 | $48.83K | BUY | 630.00% | 36.50K | May 10 - May 11 | View |
| May 11, 2023 | STEPHEN ROCAMBOLI | DIRECTOR | 8.11K | $1.50 | $12.13K | BUY | ∞ | 8.11K | May 10 | View |
| May 10, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | 20.00K | $1.26 | $25.19K | BUY | 6.83% | 312.82K | May 09 | View |
| Apr 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -115.00 | $1.28 | -$146.97 | SELL | -0.16% | 70.23K | Apr 19 | View |
| Apr 20, 2023 | Benjamin Looker | GENERAL COUNSEL | -1.29K | $1.27 | -$1.64K | SELL | -1.52% | 83.66K | Apr 19 | View |
| Apr 20, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -938.00 | $1.27 | -$1.19K | SELL | -0.73% | 127.06K | Apr 19 | View |
| Mar 20, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.81K | $1.78 | -$6.79K | SELL | -2.89% | 128.00K | Mar 17 | View |
| Mar 20, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | -7.00K | $1.78 | -$12.48K | SELL | -2.33% | 292.82K | Mar 17 | View |
| Mar 20, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -526.00 | $1.78 | -$937.49 | SELL | -0.74% | 70.35K | Mar 17 | View |
| Mar 08, 2023 | Eric Warren | CHIEF COMMERCIAL OFFICER | -5.09K | $5.05 | -$25.73K | SELL | -9.49% | 48.57K | Mar 07 | View |
| Mar 08, 2023 | Sheldon L Koenig | PRESIDENT AND CEO | -5.44K | $5.06 | -$27.51K | SELL | -2.72% | 194.81K | Mar 07 | View |
| Mar 08, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.88K | $5.07 | -$19.67K | SELL | -3.63% | 103.06K | Mar 07 | View |
| Jan 19, 2023 | Benjamin Looker | GENERAL COUNSEL | -6.35K | $7.00 | -$44.40K | SELL | -8.96% | 64.45K | Jan 18 | View |
| Jan 19, 2023 | Joanne Foody | CHIEF MEDICAL OFFICER | -1.19K | $6.99 | -$8.32K | SELL | -1.10% | 106.94K | Jan 18 | View |
| Oct 19, 2022 | Joanne Foody | CHIEF MEDICAL OFFICER | -942.00 | $7.69 | -$7.24K | SELL | -0.86% | 108.14K | Oct 18 | View |
| Oct 19, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -107.00 | $7.69 | -$822.83 | SELL | -0.20% | 53.66K | Oct 18 | View |
| Sep 20, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -255.00 | $6.92 | -$1.76K | SELL | -0.47% | 53.77K | Sep 19 | View |
| Sep 20, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | -3.39K | $6.94 | -$23.55K | SELL | -1.68% | 198.26K | Sep 19 | View |
| Aug 31, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | 1.00K | $7.46 | $7.46K | BUY | 1.89% | 54.02K | Aug 31 | View |
| Aug 18, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -199.00 | $6.82 | -$1.36K | SELL | -0.37% | 53.02K | Aug 17 | View |
| Aug 08, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | 8.61K | $5.80 | $49.95K | BUY | 4.53% | 198.77K | Aug 05 | View |
| Jul 20, 2022 | Joanne Foody | CHIEF MEDICAL OFFICER | -3.90K | $6.55 | -$25.55K | SELL | -3.45% | 109.08K | Jul 19 | View |
| Jul 20, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -431.00 | $6.58 | -$2.84K | SELL | -0.80% | 53.22K | Jul 19 | View |
| Jun 21, 2022 | Sheldon L Koenig | PRESIDENT AND CEO | -4.55K | $4.99 | -$22.72K | SELL | -2.34% | 190.16K | Jun 17 | View |
| Jun 21, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -256.00 | $4.90 | -$1.25K | SELL | -0.47% | 53.65K | Jun 17 | View |
| Jun 03, 2022 | MARTIN CARROLL | DIRECTOR | 5.00K | $5.64 | $28.18K | BUY | ∞ | 5.00K | Jun 02 | View |
| May 18, 2022 | Eric Warren | CHIEF COMMERCIAL OFFICER | -196.00 | $5.98 | -$1.17K | SELL | -0.36% | 53.91K | May 17 | View |
| Mar 18, 2022 | Sheldon Koenig | PRESIDENT AND CEO | -571.00 | $4.58 | -$2.62K | SELL | -0.29% | 194.72K | Mar 17 | View |
| May 26, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 100.00K | $20.22 | $2.02M | BUY | 2.28% | 4.48M | May 24 | View |
| May 21, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 200.00K | $20.37 | $4.07M | BUY | 4.79% | 4.38M | May 19 | View |
| May 07, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 230.00K | $20.21 | $4.65M | BUY | 5.83% | 4.18M | May 05 - May 06 | View |
| Nov 04, 2020 | TARGET BIOTECH VAG BIOTECH BB | — | 200.00K | $25.31 | $5.06M | PURCHASE | 5.34% | 3.95M | Nov 03 | View |
| Mar 12, 2020 | TIMOTHY MAYLEBEN | — | 2.50K | $43.00 | $107.50K | PURCHASE | 2.28% | 112.00K | Mar 11 | View |
| Mar 02, 2020 | TIMOTHY MAYLEBEN | — | 5.00K | $49.00 | $245.00K | PURCHASE | 4.78% | 109.50K | Feb 28 | View |
| Jan 27, 2020 | TARGET BIOTECH VAG BIOTECH BB | — | 20.00K | $52.12 | $1.04M | PURCHASE | 0.54% | 3.75M | Jan 23 | View |
| Nov 08, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $36.98 | $184.90K | BUY | 6.36% | 83.66K | Nov 06 | View |
| Nov 08, 2019 | BB Biotech AG Ivo BetschartBB Biotech AG | 10% OWNER | 75.00K | $37.30 | $2.80M | BUY | 2.05% | 3.73M | Nov 06 | View |
| Sep 06, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 7.50K | $34.55 | $259.11K | BUY | 10.54% | 78.66K | Sep 04 - Sep 06 | View |
| Sep 06, 2019 | BB Biotech AG Ivo BetschartBB Biotech AG | 10% OWNER | 80.00K | $33.78 | $2.70M | BUY | 2.24% | 3.65M | Sep 04 | View |
| Aug 02, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $39.56 | $197.80K | BUY | 7.56% | 71.16K | Aug 01 | View |
| Jul 25, 2019 | BB Biotech AG Martin GublerBB Biotech AG | 10% OWNER | 50.00K | $42.65 | $2.13M | BUY | 1.42% | 3.57M | Jul 23 | View |
| Jul 01, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $46.00 | $230.00K | BUY | 8.17% | 66.16K | Jun 28 | View |
| Apr 05, 2019 | Richard Bartram | CHIEF FINANCIAL OFFICER | 8.00K | $42.88 | $343.05K | s | 258.73% | 11.09K | Apr 03 | View |
| Apr 01, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $40.00 | $200.00K | BUY | 8.90% | 61.16K | Mar 29 | View |
| Mar 21, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $43.48 | $217.40K | BUY | 9.77% | 56.16K | Mar 20 | View |
| Mar 21, 2019 | NICOLE VITULLO | DIRECTOR | -1.12M | $44.73 | -$685.60K | SELL | -99.26% | 8.32K | Mar 19 - Mar 21 | View |
| Mar 15, 2019 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 50.00K | $49.89 | $2.49M | BUY | 1.44% | 3.52M | Mar 14 | View |
| Mar 14, 2019 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 5.00K | $48.73 | $243.65K | BUY | 10.83% | 51.16K | Mar 14 | View |
| Mar 14, 2019 | ROGER NEWTON | DIRECTOR | -25.00K | $50.06 | -$1.25M | SELL | -4.36% | 548.73K | Mar 12 | View |
| Jan 07, 2019 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 80.00K | $41.29 | $3.30M | BUY | 2.36% | 3.47M | Jan 04 | View |
| Dec 26, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 50.00K | $39.91 | $2.00M | BUY | 1.50% | 3.39M | Dec 24 | View |
| Dec 19, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 60.00K | $47.73 | $2.86M | BUY | 1.83% | 3.34M | Dec 17 | View |
| Nov 05, 2018 | Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWIS | 10% OWNER | -100.00K | $56.38 | -$5.64M | SELL | -8.32% | 1.10M | Nov 02 - Nov 05 | View |
| Nov 02, 2018 | ROGER NEWTON | DIRECTOR | -2.83K | $50.07 | -$141.55K | SELL | -0.49% | 573.73K | Nov 01 - Nov 02 | View |
| Oct 18, 2018 | ROGER NEWTON | DIRECTOR | -22.17K | $50.02 | -$1.11M | SELL | -3.70% | 576.55K | Oct 16 - Oct 18 | View |
| Aug 29, 2018 | ROGER NEWTON | DIRECTOR | -17.70K | $51.05 | -$903.61K | SELL | -2.87% | 598.73K | Aug 27 | View |
| Aug 22, 2018 | ROGER NEWTON | DIRECTOR | -7.30K | $50.06 | -$365.44K | SELL | -1.17% | 616.43K | Aug 17 | View |
| Aug 06, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 50.00K | $46.14 | $2.31M | BUY | 1.55% | 3.28M | Aug 03 | View |
| Jul 13, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 50.00K | $41.77 | $2.09M | BUY | 1.57% | 3.23M | Jul 12 | View |
| Jul 03, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 50.00K | $39.48 | $1.97M | BUY | 1.60% | 3.18M | Jun 29 | View |
| Jun 25, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 60.00K | $38.57 | $2.31M | BUY | 1.95% | 3.13M | Jun 21 | View |
| Jun 11, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 60.00K | $37.79 | $2.27M | BUY | 1.99% | 3.07M | Jun 07 | View |
| Jun 07, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 60.00K | $38.47 | $2.31M | BUY | 2.03% | 3.01M | Jun 05 | View |
| May 22, 2018 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 130.00K | $40.11 | $5.21M | BUY | 4.61% | 2.95M | May 18 - May 21 | View |
| Mar 29, 2018 | ROGER NEWTON | DIRECTOR | 6.91K | $72.56 | $484.15K | s | 1.12% | 623.73K | Mar 29 | View |
| Jan 26, 2018 | NICOLE VITULLO | DIRECTOR | -796.73K | $39.40 | -$837.93K | SELL | -97.00% | 24.65K | Jan 24 - Jan 26 | View |
| Dec 08, 2017 | NICOLE VITULLO | DIRECTOR | -365.21K | $53.85 | -$502.21K | SELL | -93.85% | 23.94K | Dec 06 - Dec 08 | View |
| Mar 23, 2017 | Daniel Janney | DIRECTOR | -350.00K | $45.80 | -$16.03M | SELL | -20.38% | 1.37M | Mar 21 | View |
| Mar 23, 2017 | Dov Goldstein | DIRECTOR | -800.00K | $41.66 | -$33.33M | SELL | -48.87% | 837.13K | Mar 21 - Mar 22 | View |
| Mar 22, 2017 | GILBERT OMENN | DIRECTOR | 1.00K | $42.26 | $42.26K | BUY | 10.00% | 11.00K | Mar 21 | View |
| Nov 03, 2016 | Narendra Lalwani | CHIEF OPERATING OFFICER | 5.00K | $9.93 | $49.65K | BUY | ∞ | 5.00K | Nov 01 | View |
| Jul 07, 2016 | MARK MCGOVERN | DIRECTOR | 5.00K | $10.00 | $50.00K | BUY | ∞ | 5.00K | Jul 05 - Jul 06 | View |
| May 05, 2016 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 7.00K | $14.85 | $103.95K | BUY | 20.22% | 41.61K | May 04 | View |
| Mar 02, 2016 | GILBERT OMENN | DIRECTOR | 5.00K | $15.28 | $76.40K | BUY | 100.00% | 10.00K | Mar 01 | View |
| Jan 28, 2016 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 3.60K | $15.88 | $57.17K | BUY | 11.61% | 34.61K | Jan 27 | View |
| Jan 19, 2016 | TIMOTHY MAYLEBEN | PRESIDENT & CEO | 7.20K | $14.08 | $101.38K | BUY | 30.23% | 31.01K | Jan 15 | View |
| Apr 27, 2015 | Aisling Capital II LPAISLING CAPITAL PARTNERS LPAISLING CAPITAL PARTNERS LLCANDREW SCHIFFDennis PurcellSTEVE ELMS | 10% OWNER | -217.47K | $108.22 | -$23.53M | SELL | -10.58% | 1.84M | Apr 23 - Apr 24 | View |
| Apr 27, 2015 | Dov Goldstein | DIRECTOR | -217.47K | $108.22 | -$23.53M | SELL | -10.58% | 1.84M | Apr 23 - Apr 24 | View |
| Mar 23, 2015 | Patrick G Enright | DIRECTOR | -500.00K | $111.66 | -$55.83M | SELL | -96.46% | 18.36K | Mar 19 | View |
| Nov 19, 2014 | Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms | 10% OWNER | -487.13K | $32.78 | -$15.97M | SELL | -94.53% | 28.19K | Nov 17 - Nov 18 | View |
| Nov 19, 2014 | Patrick G Enright | DIRECTOR | -487.13K | $32.78 | -$15.97M | SELL | -94.53% | 28.19K | Nov 17 - Nov 18 | View |
| Oct 21, 2014 | Alta Partners VIII LPAlta Partners Management VIII LLCFARAH CHAMPSIGUY NOHRA | 10% OWNER | 500.00K | $20.00 | $10.00M | BUY | 24.36% | 2.55M | Oct 21 | View |
| Oct 21, 2014 | Daniel Janney | DIRECTOR | 500.00K | $20.00 | $10.00M | BUY | 24.36% | 2.55M | Oct 21 | View |
| Oct 21, 2014 | GILBERT OMENN | DIRECTOR | 5.00K | $20.00 | $100.00K | BUY | ∞ | 5.00K | Oct 21 | View |
| Oct 21, 2014 | PARTERS DOMAIN VIIJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakKathleen K SchoemakerJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. Halak | DIRECTOR | 500.00K | $20.00 | $10.00M | BUY | 24.19% | 2.57M | Oct 21 | View |
| Oct 14, 2014 | Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms | 10% OWNER | -943.00 | $30.00 | -$28.29K | SELL | -2.44% | 37.76K | Oct 09 | View |
| Oct 14, 2014 | Patrick G Enright | DIRECTOR | -943.00 | $30.00 | -$28.29K | SELL | -2.44% | 37.76K | Oct 09 | View |
| Oct 09, 2014 | Patrick G Enright | DIRECTOR | -11.93K | $30.04 | -$358.29K | SELL | -24.00% | 37.78K | Oct 07 | View |
| Oct 09, 2014 | Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms | 10% OWNER | -11.93K | $30.04 | -$358.29K | SELL | -24.00% | 37.78K | Oct 07 | View |
| Jul 02, 2013 | JAMES BLAIR | 10% OWNER | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | DP VII ASSOCIATES LP | 10% OWNER | 35.25K | $14.00 | $67.07K | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | Kathleen K. Schoemaker Managing Member of One Palmer Square Associates VII, LLC, General Partner of Domain Partners VII, L.P. | 10% OWNER | 2.07M | $14.00 | $3.93M | BUY | ∞ | 2.07M | Jul 01 | View |
| Jul 02, 2013 | Brian Halak | 10% OWNER | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | BRIAN DOVEY | 10% OWNER | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | Kathleen K Schoemaker | 10% OWNER | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | JESSE TREU | 10% OWNER | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 02, 2013 | NICOLE VITULLO | DIRECTOR | 2.10M | $14.00 | $4.00M | BUY | ∞ | 35.25K | Jul 01 | View |
| Jul 01, 2013 | Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms | 10% OWNER | 1.93M | $14.00 | $3.03M | BUY | ∞ | 38.01K | Jul 01 | View |
| Jul 01, 2013 | TIMOTHY MAYLEBEN | PRESIDENT AND CEO | 5.00K | $14.00 | $70.00K | BUY | 21.00% | 28.81K | Jul 01 | View |
| Jul 01, 2013 | ROGER NEWTON | EXECUTIVE CHAIRMAN, CSO | 343.40K | $14.00 | $592.84K | BUY | 119.95% | 629.68K | Jul 01 | View |
| Jul 01, 2013 | LOUIS LANGE | DIRECTOR | 215.52K | $14.00 | $199.00K | BUY | ∞ | 197.70K | Jul 01 | View |
| Jul 01, 2013 | MD DOV GOLDSTEIN | DIRECTOR | 2.05M | $14.00 | $3.33M | BUY | ∞ | 2.05M | Jul 01 | View |
| Jul 01, 2013 | PATRICK ENRIGHT | DIRECTOR | 1.93M | $14.00 | $3.03M | BUY | ∞ | 38.01K | Jul 01 | View |
| Jul 01, 2013 | DANIEL JANNEY | DIRECTOR | 2.05M | $14.00 | $3.30M | BUY | ∞ | 2.05M | Jul 01 | View |
| Jul 01, 2013 | Alta Partners VIII LPAlta Partners Management VIII LLCFARAH CHAMPSIGUY NOHRA | 10% OWNER | 2.05M | $14.00 | $3.30M | BUY | ∞ | 2.05M | Jul 01 | View |
| Jul 01, 2013 | Aisling Capital II LPAISLING CAPITAL PARTNERS LPAISLING CAPITAL PARTNERS LLCANDREW SCHIFFDennis PurcellSTEVE ELMS | 10% OWNER | 2.05M | $14.00 | $3.33M | BUY | ∞ | 2.05M | Jul 01 | View |
よくある質問
Q
インサイダー取引は合法ですか？
A
インサイダー取引は、インサイダーがその取引をSECに報告する限り合法である。違法な証券取引は、インサイダーが受託者の義務に違反しているか、取引を報告していない場合に発生する。
Q
市場操作の例を教えてください。
A
インサイダー取引、パンプ・アンド・ダンプ・スキーム、フロント・ランニング、ウォッシュ・トレードはすべて市場操作の例である。インサイダーの資産の動きを追跡する投資家は、前進する前に、これらのインサイダーがなぜ株式を取引しているのかについて慎重に考えるべきである。
ESPR インサイダー取引ニュース
こんな人も見ています
Benzinga
© 2026 Benzinga | All Rights Reserved